Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-003157

Options or other derivatives

  • Senior VP and General Counsel acquired 84,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LADD CYNTHIA J · Senior VP and General Counsel

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-01-25 Grant or award : show line 1 in the form Stock Option (right to buy) +84,000 84,000 D
Loading xslF345X03/doc1.xml…